Association Between Fever and Antibody Titer Trends After a Third Dose of the mRNA-1273 Vaccine
J Epidemiol
.
2022 Dec 5;32(12):567-569.
doi: 10.2188/jea.JE20220210.
Epub 2022 Sep 30.
Authors
Naomi Matsumoto
1
,
Tomoka Kadowaki
2
,
Rumi Matsuo
2
,
Ayako Sasaki
1
,
Chikara Miyaji
2
3
,
Chigusa Higuchi
3
,
Masanori Nakayama
4
,
Yasue Sakurada
5
,
Hideharu Hagiya
5
,
Soshi Takao
1
,
Fumio Otsuka
5
6
,
Takashi Yorifuji
1
Affiliations
1
Department of Epidemiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University.
2
Department of Epidemiology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences.
3
Okayama University Health Service Center.
4
Office of Innovative Medicine, Organization for Research Strategy and Development, Okayama University.
5
Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences.
6
Clinical Laboratory, Okayama University Hospital.
PMID:
36031363
PMCID:
PMC9643792
DOI:
10.2188/jea.JE20220210
No abstract available
Keywords:
SARS-CoV-2; adverse reaction; antibody; mRNA-1273; reactogenicity.
Publication types
Research Support, Non-U.S. Gov't
Letter
MeSH terms
2019-nCoV Vaccine mRNA-1273*
Humans
Substances
2019-nCoV Vaccine mRNA-1273